ARCHIVES

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Early ADT Doesn’t Offer Survival Advantage—ASCO

April 27, 2007

Clinical Study Group Proposed To Examine Peer Review System

October 15, 1993

Smoking/Health Program Seeks Grants; Ideas For RFAs RFPs Being Considered

December 5, 1980

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

UICC Fellowship, Exchange Programs

July 5, 1985

In Brief: Columbia Still In Running As Comprehensive Center In ’78; Illinois Withdraws Application

June 24, 1977